323990 Stock Chart & Stats
₩3930.00
-₩60.00(-1.50%)
―
--
Day’s Range― - ―
52-Week Range₩3,350.00 - ₩11,520.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)216.68K
Market Cap
₩92.46B
Enterprise Value₩105.13K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-174.60
Shares Outstanding23,257,345
10 Day Avg. Volume92,701
30 Day Avg. Volume216,684
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
323990 FAQ
What was Vaxcell-Bio Therapeutics’s price range in the past 12 months?
Vaxcell-Bio Therapeutics lowest stock price was ₩3350.00 and its highest was ₩11520.00 in the past 12 months.
What is Vaxcell-Bio Therapeutics’s market cap?
Vaxcell-Bio Therapeutics’s market cap is ₩92.46B.
When is Vaxcell-Bio Therapeutics’s upcoming earnings report date?
Vaxcell-Bio Therapeutics’s upcoming earnings report date is Nov 12, 2026 which is in 77 days.
How were Vaxcell-Bio Therapeutics’s earnings last quarter?
Vaxcell-Bio Therapeutics released its earnings results on Aug 14, 2026. The company reported -₩174.605 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Vaxcell-Bio Therapeutics overvalued?
According to Wall Street analysts Vaxcell-Bio Therapeutics’s price is currently Undervalued.
Does Vaxcell-Bio Therapeutics pay dividends?
Vaxcell-Bio Therapeutics does not currently pay dividends.
What is Vaxcell-Bio Therapeutics’s EPS estimate?
Vaxcell-Bio Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vaxcell-Bio Therapeutics have?
Vaxcell-Bio Therapeutics has 23,257,345 shares outstanding.
What happened to Vaxcell-Bio Therapeutics’s price movement after its last earnings report?
Vaxcell-Bio Therapeutics reported an EPS of -₩174.605 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.839%.
Which hedge fund is a major shareholder of Vaxcell-Bio Therapeutics?
Currently, no hedge funds are holding shares in KR:323990
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cell Biotech Co., Ltd
―
HYUNDAI BIOLAND Co.,Ltd.
―
Choong Ang Vaccine Laboratory
―
OPTUS Pharmaceutical Co. Ltd.
―
WITHUS PHARMACEUTICAL Co., Ltd.
―